Meis

The latest newsletter from Stop You're Killing Meis just out, with news of the recent Agatha award winners for this year, Macavity nominees and listings of May hardcover, paperback, audio and large print releases in the USA.

Books Maxine 2009

The latest newsletter from Stop You're Killing Meis just out, with news of the recent Agatha award winners for this year, Macavity nominees and listings of May hardcover, paperback, audio and large print releases in the USA.

While I was gone Maxine 2009

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012

The latest newsletter from Stop You're Killing Meis just out, with news of the recent Agatha award winners for this year, Macavity nominees and listings of May hardcover, paperback, audio and large print releases in the USA.

May 2009 Maxine 2009

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012

But in the case of progesterone, the research came first -- in 2003 when landmark papers by Meis and da Fonseca were published -- and since the drug was already available for other indications, most of the marketing was done in the very best way -- by leading obstetricians who had no vested interest in one company or another advocating use of a generic compound that was proven to solve a clinical problem.

Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market M.D. Adam Wolfberg 2012